Literature DB >> 23419761

Evaluation and treatment of the newborn with epidermolysis bullosa.

Mercedes E Gonzalez1.   

Abstract

Epidermolysis bullosa (EB) is a heterogeneous group of inherited skin diseases characterized by increased skin fragility and variable degrees of extracutaneous involvement. The clinical spectrum ranges from localized skin disease to a life-threatening and disabling disease with extensive extracutaneous involvement. All four major types of EB, namely EB simplex, Junctional EB, Dystrophic EB and Kindler syndrome, can present with blistering and erosions at birth and cannot be distinguished clinically in the newborn period. The extensive differential diagnosis of blistering and erosions in the neonate must be considered and common etiologies ruled out. The diagnosis of EB can be confirmed via a skin biopsy for immunoflourescence mapping. This review discusses the four major subtypes of EB and their associated extracutaneous features. The evaluation of a newborn suspected of having EB, including diagnosis and management, is also reviewed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23419761     DOI: 10.1053/j.semperi.2012.11.004

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  15 in total

1.  Cord blood platelet gel treatment of dystrophic recessive epidermolysis bullosa.

Authors:  Gianluca Tadini; Lidia Pezzani; Stefano Ghirardello; Paolo Rebulla; Susanna Esposito; Fabio Mosca
Journal:  BMJ Case Rep       Date:  2015-01-08

2.  Newborn with severe epidermolysis bullosa: to treat or not to treat?

Authors:  Martin Lehmann Boesen; Anette Bygum; Jens Michael Hertz; Gitte Zachariassen
Journal:  BMJ Case Rep       Date:  2016-04-26

3.  Urological Manifestations of Kindler Syndrome: A Case Report.

Authors:  Rudra Ghorai; Gurpremjit Singh; Ankur Mittal; Vikas K Panwar; Harkirat Talwar
Journal:  Cureus       Date:  2022-05-05

4.  High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins.

Authors:  Jingyuan Sun; Vincent E Groppi; Honglian Gui; Lu Chen; Qing Xie; Li Liu; M Bishr Omary
Journal:  Methods Enzymol       Date:  2015-11-19       Impact factor: 1.600

Review 5.  Dystrophic epidermolysis bullosa: a review.

Authors:  Satoru Shinkuma
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-26

6.  Nutritional outcomes in children with epidermolysis bullosa: the experiences of two centers in Korea.

Authors:  Kyu-Yeun Kim; Ran Namgung; Soon Min Lee; Soo Chan Kim; Ho Sun Eun; Min Soo Park; Kook In Park; Chul Lee
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

7.  Dystrophic epidermolysis bullosa in pregnancy: a case report of the autosomal dominant subtype and review of the literature.

Authors:  Nicole Colgrove; Rayan Elkattah; Howard Herrell
Journal:  Case Rep Med       Date:  2014-04-24

8.  Establishing medical plausibility in the context of orphan medicines designation in the European Union.

Authors:  Stelios Tsigkos; Segundo Mariz; Jordi Llinares; Laura Fregonese; Stiina Aarum; Frauke Naumann-Winter; Naumann-Winter Frauke; Kerstin Westermark; Bruno Sepodes
Journal:  Orphanet J Rare Dis       Date:  2014-12-05       Impact factor: 4.123

9.  A Sporadic Neonatal Case of Epidermolysis Bullosa Simplex Generalized Intermediate with KRT5 and KRT14 Gene Mutations.

Authors:  Hiroyuki Wakiguchi; Shunji Hasegawa; Shinji Maeba; Sasagu Kimura; Satoko Ito; Hiroshi Tateishi; Kazuhiro Ueda; Shouichi Ohga
Journal:  AJP Rep       Date:  2016-03

10.  Clinical practice guidelines: Oral health care for children and adults living with epidermolysis bullosa.

Authors:  Susanne Krämer; James Lucas; Francisca Gamboa; Miguel Peñarrocha Diago; David Peñarrocha Oltra; Marcelo Guzmán-Letelier; Sanchit Paul; Gustavo Molina; Lorena Sepúlveda; Ignacio Araya; Rubén Soto; Carolina Arriagada; Anne W Lucky; Jemima E Mellerio; Roger Cornwall; Fatimah Alsayer; Reinhard Schilke; Mark Adam Antal; Fernanda Castrillón; Camila Paredes; Maria Concepción Serrano; Victoria Clark
Journal:  Spec Care Dentist       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.